Pancreatic Cancer is Deadly… ValAsta Can Help

Research has shown that ValAsta/Astaxanthin can be used to fight the gemcitabine-resistant pancreatic tumors.

Pancreatic cancer is a lethal malignancy, with a mortality rate of >90%; it is ranked fourth in terms of cancer-related deaths. Treatment of pancreatic cancer involves chemotherapy. The tumor rapidly becomes resistance to this treatment resulting in the cancer being difficult to treat and with a poor outcome. The attached study shows how Astaxanthin can prevent the tumor from becoming resistant to the chemotherapy and allowing for a better outcome.

Signs and symptoms of pancreatic cancer often don’t occur until the disease is advanced.

Symptoms may include:

  1. Pain in the upper abdomen that radiates to your back
  2. Loss of appetite or unintended weight loss
  3. Depression
  4. New-onset diabetes
  5. Blood clots
  6. Fatigue
  7. Yellowing of your skin and the whites of your eyes (jaundice)

PMC Article – November 2017